Equillium

La Jolla, United States

Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.

$35.0M raised

Mar 2026

Post Ipo Equity

Top Investors

RA Capital ManagementAlumni VenturesJanus Henderson InvestorsAdage Capital ManagementDecheng Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Equillium raised?

Equillium has raised $35.0M in total funding. The most recent round was Post Ipo Equity. The last funding was announced in March 2026.

Who are Equillium's investors?

Equillium's investors include RA Capital Management, Alumni Ventures, Janus Henderson Investors, Adage Capital Management, Decheng Capital.

Where is Equillium headquartered?

Equillium is headquartered in La Jolla, United States.

What does Equillium do?

Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.

What stage is Equillium at?

Equillium is at the Post Ipo Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 13, 2026.

MLA

"Equillium — Funding & Investors." VCBacked, March 13, 2026, https://www.vcbacked.co/company/equillium. Accessed June 3, 2026.

APA

VCBacked. (2026). Equillium — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/equillium

Wikipedia (cite web)

{{cite web |title=Equillium — Funding & Investors |url=https://www.vcbacked.co/company/equillium |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 13, 2026.